Transgenic rabbits as models for atherosclerosis research

Journal of Lipid Research

Volumn 40, Issue 3, 1999, Pages 365-375

  Brousseau, Margaret E ^a   Hoeg, Jeffrey M ^b  

^a TUFTS UNIVERSITY   (United States)

^b NONE

Author keywords

Atherosclerosis; Lipid enzymes; New Zealand White; Transgenic; Watanabe Heritable Hyperlipidemic

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN B; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; CELL ENZYME; CHOLESTEROL ESTER TRANSFER PROTEIN; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN RECEPTOR; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE;

ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; DISEASE PREDISPOSITION; ENZYME ACTIVITY; EXPERIMENTAL MODEL; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILIAL HYPERLIPEMIA; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; REVIEW; STRAIN DIFFERENCE; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; APOLIPOPROTEINS; ARTERIOSCLEROSIS; DISEASE MODELS, ANIMAL; HUMANS; LIPASE; LIPOPROTEINS; LIVER; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; RABBITS; RNA, MESSENGER;

EID: 0033046566     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Chapman, M. J. 1980. Animal lipoproteins: chemistry, structure, and comparative aspects. J. Lipid Res. 21: 789-853.
2. Greeve, J., I. Altkemper, J-H. Dieterich, H. Greten, and E. Windler. 1993. Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB-containing lipoproteins. J. Lipid Res. 34: 1367-1383.
3. Nagashima, M., J. W. McLean, and R. L. Lawn. 1988. Cloning and mRNA tissue distribution of rabbit cholesteryl ester transfer protein. J. Lipid Res. 29: 1643-1649.
4. Tall, A. 1993. Plasma cholesteryl ester transfer protein. J. Lipid Res. 34: 1255-1274.
5. Duff, G. L. 1935. Experimental cholesterol arteriosclerosis and its relationship to human arteriosclerosis. Arch. Pathol. 20: 81-123, 259-304.
6. Clarkson, T. B., N. D. M. Lehner, and B. C. Bullock. 1974. Specialized research applications: I. Arteriosclerosis research. In The Biology of the Laboratory Rabbit. S. H. Weisbroth, R. E. Flatt, and A. L. Krauss, editors. Academic Press, San Diego. 155-165.
7. Paigen, B., B. Y. Ishida, J. Verstuyft, R. B. Winters, and D. Albee. 1990. Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice. Arteriosclerosis. 10: 316-323.
8. Borresen, A. L., T. J. Kindt, and K. Berg. 1978. Partial purification and characterization of the inherited Hl 1 and R 67 antigens of rabbit serum high density lipoprotein. J. Immunogenet. 5: 71-86.
9. Warren, R. J., D. L. Ebert, A. Mitchell, and P. J. Barter. 1991. Rabbit hepatic lipase cDNA sequence: low activity is associated with low messenger RNA levels. J. Lipid Res. 32: 1333-1339.
10. Watanabe, Y. 1990. Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit): incidence and development of atherosclerosis and xanthoma. Atherosclerosis. 36: 261-268.
11. Tanzawa, K., Y. Shimada, M. Kuroda, Y. Tsujita, M. Arai, and Y. Watanabe. 1980. A low density lipoprotein receptor-deficient animal model for familial hypercholesterolemia. FEBS Lett. 18: 81-84.
12. La Ville, A., P. R. Turner, R. M. Pittilo, S. Martini, C. B. Marenah, P. M. Rowles, G. Morris, G. A. Thomson, N. Woolf, and B. Lewis. 1987. Hereditary hyperlipidemia in the rabbit due to overproduction of lipoproteins. I: biochemical studies. Arteriosclerosis. 7: 105-112.
13. Seddon, A. M., N. Woolf, A. La Ville, R. M. Pittilo, P. M. Rowles, P. R. Turner, and B. Lewis. 1987. Hereditary hyperlipidemia and atherosclerosis in the rabbit due to overproduction of lipoproteins. II: Preliminary report of arterial pathology. Arteriosclerosis. 7: 113-124.
14. Perevozchikov, A. P., B. L. Vaisman, A. V. Sorokin, V. I. Kuryshev, E. V. Vorob'ev, D. I. Dozortsev, G. V. Konovalov, V. A. Otellin, E. B. Dizhe, and B. V. Missiul. 1993. Study of the effect of the cDNA for the human A-I gene in transgenic rabbits: modeling the neurological syndrome of human Tangier disease. Molekuliarnaia Biologii. 27: 24-37.
15. Duverger, N., C. Viglietta, L. Berthou, F. Emmanuel, A. Tailleux, L. Parmentier-Nihoul, B. Laine, C. Fievet, G. Castro, J. C. Fruchart, L. M. Houdebine, and P. Denèfle. 1996. Transgenic rabbits expressing human apolipoprotein A-I in the liver. Arterioscler. Thromb. Vasc. Biol. 16: 1424-1429.
16. Rubin, E. M., B. Y. Ishida, S. M. Clift, and R. M. Krauss. 1991. Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two high density lipoprotein size subclasses. Proc. Natl. Acad. Sci. USA. 88: 434-438.
17. Chao, Y., T. Yamin, G. M. Thompson, and P. A. Kroon. 1984. Tissue-specific expression of genes encoding apolipoprotein E and A-I in rabbits. J. Biol. Chem. 259: 5306-5309.
18. Pan, T., Q. Hao, T. Yamin, P. Dai, B. Chen, S. Chen, P. A. Kroonand, and Y. Chao. 1987. Rabbit apolipoprotein A-I mRNA and gene: evidence that rabbit apolipoprotein A-I is synthesized in the intestine but not in the liver. Eur. J. Biochem. 170: 99-104.
19. Duverger, N., H. Kruth, F. Emmanuel, J-M. Caillaud, C. Viglietta, G. Castro, A. Tailleux, C. Fievet, J. C. Fruchart, L. M. Houdebine, and P. Denèfle. 1996. Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I transgenic rabbits. Circulation. 94: 713-717.
20. Lebuffe, G., A. Boullier, A. Tailleux, B. Delfly, B. Dupuis, J. C. Fruchart, N. Duverger, F. Emmanuel, P. Denèfle, B. Vallet, and P. Duriez. 1997. Endothelial derived vasorelaxation is impaired in human apoA-I transgenic rabbits. Biochem. Biophys. Res. Commun. 241: 205-211.
21. Cooke, J. P., A. H. Singer, P. Tsao, P. Zera, R. A. Rowan, and M. E. Billingham. 1992. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J. Clin. Invest. 90: 1168-1172.
22. Wang, B. Y., A. H. Singer, P. S. Tsao, H. Drexler, J. Kosek, and J. P. Cooke. 1994. Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit. J. Am. Coll. Cardiol. 23: 452-458.
23. Fan, J., S. P. A. McCormick, R. M. Krauss, S. Taylor, R. Quan, J. M. Taylor, and S. G. Young. 1995. Overexpression of human apolipoprotein B-100 in transgenic rabbits results in increased levels of LDL and decreased levels of HDL. Arterioscler: Thromb. Vasc. Biol. 15: 1889-1899.
24. Linton, M. F., R. V. Farese, Jr., G. Chiesa, D. S. Grass, P. Chin, R. E. Hammer, H. H. Hobbs, and S. G. Young. 1993. Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein (a). J. Clin. Invest. 92: 3029-3037.
25. Rouy, D., N. Duverger, S. D. Lin, F. Emmanuel, I.-M. Houdebine, P. Denèfle, C. Viglietta, E. Gong, E. M. Rubin, and S. D. Hughes. 1998. Apolipoprotein (a) yeast artificial chromosome transgenic rabbits. J. Biol. Chem. 273: 1247-1251.
26. Callow, M. J., L. J. Stoltzfus, R. M. Lawn, and E. M. Rubin. 1994. Expression of human apolipoprotein B and assembly of lipoprotein (a) in transgenic mice. Proc. Natl. Acad. Sci. USA. 91: 2130-2136.
27. Frazer, K. A., G. Narla, J. L. Zhang, and E. M. Rubin. 1995. The apolipoprotein(a) gene is regulated by sex hormones and acute-phase inducers in YAC mice. Nat. Genet. 9: 424-431.
28. Trieu, V., and W. J. McConathy. 1995. The binding of animal lowdensity lipoproteins to human apolipoprotein(a). Biochem. J. 309: 899-904.
29. Huang, Y., S. W. Schwendner, S. C. Rall, Jr., D. A. Sanan, and R. W. Mahley. 1997. Apolipoprotein E2 transgenic rabbits: modulation of the type III hyperlipoproteinemic phenotype by estrogen and occurrence of spontaneous atherosclerosis. J. Biol. Chem. 272: 22685-22694.
30. Simonet, W. S., N. Bucay, S. J. Lauer, and J. M. Taylor. 1993. A far- down-stream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C-I genes in transgenic mice. J. Biol. Chem. 268: 8221-8229.
31. Fan, J., J. Zhong-Sheng, Y. Huang, H. de Silva, D. Sanan, R. W. Mahley, T. L. Innerarity, and J. M. Taylor. 1998. Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma. J. Clin. Invest. 101: 2151-2164.
32. Choi, S. Y., L. G. Fong, M. J. Kirven, and A. D. Cooper. 1991. Use of an anti-low density lipoprotein receptor antibody to quantify the role of the LDL receptor in the removal of chylomicron remnants in the mouse in vivo. J. Clin. Invest. 88: 1173-1181.
33. Koo, C., M. E. Wernette-Hammond, Z. Garcia, M. J. Malloy, R. Uauy, C. East, D. W. Bilheimer, R. W. Mahley, and T. L. Innerarity. 1988. Uptake of cholesterol-rich remnant lipoproteins by human monocyte-derived macrophages is mediated by low density lipoprotein receptors. J. Clin. Invest. 81: 1332-1340.
34. Kowal, R. C., J. Herz, J. L. Goldstein, V. Esser, and M. S. Brown. 1989. Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins. Proc. Natl. Acad. Sci. USA. 86: 5810-5814.
35. Ji, Z-S., W. J. Brecht, R. D. Miranda, M. M. Hussain, T. L. Innerarity, and R. W. Mahley. 1993. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. J. Biol. Chem. 268: 10160-10167.
36. Taylor, J. M. 1997. Transgenic rabbit models for the study of atherosclerosis. Ann. NY Acad. Sci. 811: 146-152.
37. Hoeg, J. M., B. L. Vaisman, S. J. Demosky, Jr., S. Santamarina-Fojo, H. B. Brewer, Jr., A. T. Remaley, R. F. Hoyt, and S. Feldman. 1993. Development of transgenic Watanabe Heritable Hyperlipidemic rabbits expressing human apolipoprotein A-I. Circulation. 88: 1-2.
38. Emmanuel, F. J. M. Cailland, N. Hennuyer, C. Fievet, I. Viry, L. M. Houdebine, J. C. Fruchart, P. Denèfle, and N. Duverger. 1996. Overexpression of human apolipoprotein A-I inhibits atherosclerosis development in Watanabe rabbits. Circulation. 94: 1-632.
39. Yamanaka, S., M. E. Balestra, L. D. Ferrell, J. Fan, K. S. Arnold, S. Taylor, J. M. Taylor, and T. L. Innerarity. 1995. Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc. Natl. Acad. Sci. USA. 92: 8483-8487.
40. Yamanaka, S., K. S. Poksay, M. E. Balestra, G-Q. Zeng, and T. L. Innerarity. 1994. Cloning and mutagenesis of the rabbit apoB mRNA editing protein: a zinc motif is essential for catalytic activity, and noncatalytic auxilliary factor(s) of the editing complex are widely distributed. J. Biol. Chem. 269: 21725-21734.
41. Fan, J., J. Wang, A. Bensadoun, S. J. Lauer, Q. Dang, R. W. Mahley, and J. M. Taylor. 1994. Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc. Natl. Acad. Sci. USA. 91: 8724-8728.
42. Connelly, P. W., G. F. Maguire, M. Lee, and J. A. Little. 1990. Plasma lipoproteins in familial hepatic lipase deficiency. Arteriosclerosis. 10: 40-48.
43. Hoeg, J. M., B. L. Vaisman, S. J. Demosky, Jr., S. M. Meyn, G. D. Talley, R. F. Hoyt, Jr., S. Feldman, A. M. Bérard, N. Sakai, D. W. Wood, M. K. Brousscau, S. Marcovina, H. B. Brewer, Jr., and S. Santama-rina-Fojo. 1996. Lecithin:cholesterol acyltransferase overexpression generates hyperalpha-lipoproteinemia and a nonatherogenic lipoprotein pattern in transgenic rabbits. J. Biol. Chem. 271: 4396-4402.
44. Vaisman, B. L., H-G. Klein, M. Rouis, A. M. Berard, M. R. Kindt, G. D. Talley, S. M. Meyn, R. F. Hoyt, Jr., S. M. Marcovina, J. J. Albers, J. M. Hoeg, H. B. Brewer, Jr., and S. Santamarina-Fojo. 1995. Overexpression of human lecithin cholesterol acyltransferase leads to hyper-alphalipoproteinemia in transgenic mice. J. Biol. Chem. 270: 12269-12275.
45. Brousseau, M. E., S. Santamarina-Fojo, L. A. Zech, A. M. Bérard, B. L. Vaisman, S. M. Meyn, D. Powell, H. B. Brewer, Jr., and J. M. Hoeg. 1990. Hyperalphalipoproteinemia in human lecithin:cholesterol acyltransferase transgenic rabbits: in vivo apolipoprotein A-I catabolism is delayed in a gene dose-dependent manner. J. Clin. Invest. 97: 1844-1851.
46. Brousseau, M. E., R. D. Phair, J. Wang, B. L. Vaisman, G. D. Talley, S. Santamarina-Fojo, H. B. Brewer, Jr., and J. M. Hoeg. 1997. Overexpression of LCAT in transgenic rabbits enhances LDL catabolism via the LDI. receptor pathway. Circulation. 96: 1-230.
47. Hoeg, J. M., S. Santamarina-Fojo, A. M. Bérard, J. F. Cornhill, E. E. Herderick, S. H. Feldman, C. C. Haudenschild, B. L. Vaisman, R. F. Hoyt, Jr., S. J. Demosky, Jr., R. D. Kauffman, C. M. Hazel, S. M. Marcovina, and H. B. Brewer, Jr. 1996. Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis. Proc. Natl. Acad. Sci. USA. 93: 11448-11453.
48. Brousseau, M. E., S. Santamarina-Fojo, B. L. Vaisman, D. Applebaum-Bowden, A. M. Bérard, G. D. Talley, H. B. Brewer, Jr., and J. M. Hoeg. 1997. Overexpression of human lecithin:cholesterol acyltransferase in cholesterol-fed rabbits: LDL metabolism and HDL metabolism are affected in a gene dose-dependent manner. J. Lipid Res. 38: 2537-2547.
49. Brousseau, M. E., J. Wang, S. J. Demosky, Jr., B. L. Vaisman, G. D. Talley, S. Santamarina-Fojo, H. B. Brewer, Jr., and J. M. Hoeg. 1998. Correction of hypoalphalipoproteinemia in LDL receptor-deficient rabbits by lecithin:cholesterol acyltransferase. J. Lipid Res. 39: 1558-1567.
50. Hoeg, J. M., R. D. Kauffman, E. Herderick, S. J. Demosky, Jr., W. Evans, and M. E. Brousseau. 1998. Lecithin:cholesterol acyltransferase requires functional LDL receptors to prevent atherosclerosis. Circulation. 98: 1-464.
51. Fan, J., J. Wang, X-S. Ji, D. Sanan, Q. Dang, A. Bensadoun, R. W. Mahley, and J. M. Taylor. 1994. Transgenic rabbits overexpressing human hepatic lipase have reduced levels of high density lipoproteins and intermediate density lipoproteins and diminished responses to dietary cholesterol. Circulation. 90: 1-289.